Fasvivo Injection belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.
Fasvivo Injection contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Fasvivo Injection will be administered by a healthcare professional; do not self-administer. In some cases, Fasvivo Injection may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Fasvivo Injection do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fasvivo Injection is not recommended for pregnant women as it may harm an unborn baby. Fasvivo Injection is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fasvivo Injection. Avoid driving or operating machinery if you feel tired or weak after receiving Fasvivo Injection.